Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$817,275
+$10,868 QoQ
Shares Held
3,218
-2.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#3,207
of 4,664 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McLean Asset Management Corp holds $5,605,267 across 9 Drug Manufacturers - General names. JNJ ranks #2 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,420 | $1,703,190 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
3,218 | $817,275 | |
| 3 | ABBV |
AbbVie Inc.
|
3,136 | $789,143 | |
| 4 | AZN |
Astrazeneca PLC
|
3,240 | $614,368 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,870 | $497,295 | |
| 6 | AMGN |
Amgen Inc
|
1,064 | $385,295 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,472 | $372,916 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,768 | $223,369 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $817,275 | 3,218 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $806,407 | 3,299 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $648,995 | 3,136 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $566,458 | 3,055 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $467,720 | 3,062 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $531,185 | 3,203 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $490,261 | 3,390 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $517,295 | 3,192 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $461,134 | 3,155 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $525,507 | 3,322 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $617,242 | 3,938 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $626,270 | 4,021 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $609,444 | 3,682 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $565,595 | 3,649 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $714,195 | 4,043 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $615,050 | 3,765 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $661,224 | 3,725 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $651,497 | 3,676 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $593,441 | 3,469 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $580,592 | 3,595 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $494,549 | 3,002 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $488,283 | 2,971 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $460,493 | 2,926 | Shares | Sole | 2021-01-27 | |
| No filing history on record for this holder in this stock. | ||||||